Please use a PC Browser to access Register-Tadawul
Get It
Insights Ahead: DiaMedica Therapeutics's Quarterly Earnings
DiaMedica Therapeutics -3.23%
DiaMedica Therapeutics DMAC | 3.90 | -3.23% |
DiaMedica Therapeutics (NASDAQ:DMAC) is gearing up to announce its quarterly earnings on Tuesday, 2025-05-13. Here's a quick overview of what investors should know before the release.
Analysts are estimating that DiaMedica Therapeutics will report an earnings per share (EPS) of $-0.18.
The announcement from DiaMedica Therapeutics is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
Historical Earnings Performance
In the previous earnings release, the company missed EPS by $0.01, leading to a 13.02% drop in the share price the following trading session.
Here's a look at DiaMedica Therapeutics's past performance and the resulting price change:
| Quarter | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.17 | -0.15 | -0.16 | -0.16 |
| EPS Actual | -0.18 | -0.15 | -0.13 | -0.14 |
| Price Change % | -13.0% | -3.0% | 3.0% | -6.0% |
Stock Performance
Shares of DiaMedica Therapeutics were trading at $3.66 as of May 09. Over the last 52-week period, shares are up 28.81%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
To track all earnings releases for DiaMedica Therapeutics visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
